--- title: "ASTRAZENECA TREASURY LIMITED — Ownership Dossier" canonical: https://whiteintel.dev/entity/2763a136-67ee-56fe-abd4-5d5b1cf5dbff json: https://whiteintel.dev/api/public/dossier/2763a136-67ee-56fe-abd4-5d5b1cf5dbff identifier: oo:GB-COH-02910116 jurisdiction: GB risk: Low source: WhiteIntel corporate-ownership graph --- # ASTRAZENECA TREASURY LIMITED **Type:** Company **Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb) **Identifier:** `oo:GB-COH-02910116` **Risk level:** Low **Canonical dossier:** https://whiteintel.dev/entity/2763a136-67ee-56fe-abd4-5d5b1cf5dbff **Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/2763a136-67ee-56fe-abd4-5d5b1cf5dbff ## Cross-source identity The same real-world entity, resolved across sources: - **Astrazeneca Treasury Limited** — source · `gb-coh:2910116` — https://whiteintel.dev/entity/7f4279b9-5df2-4e84-9390-1359ded0a5a4 - **ASTRAZENECA TREASURY LIMITED** — GLEIF · `lei:213800RVA6CA8HN1RT89` — https://whiteintel.dev/entity/d57fa06e-701a-57bd-9294-d4c95a1b1571 ## Ownership & control ### Owners / controllers - **ASTRAZENECA UK LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/470a8049-6750-5b53-a977-dabd80cc8ebd - **Astrazeneca Uk Limited** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/418262bf-abfc-4e8b-a8b4-6ecf5eb55d65 ### Holdings / subsidiaries - **ARDEA BIOSCIENCES LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/f8b9d180-3db3-56ac-8745-3dfea8b2bf47 - **ASTRAPHARM** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/111cbdcc-95d0-5e53-bac3-0aa9320e2af4 - **CAMBRIDGE ANTIBODY TECHNOLOGY GROUP LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/c678c471-d990-534c-9fa7-2b102658f290 - **ZENCO (NO. 8) LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/3dfe0141-ab86-5656-92ab-fabaf0f08843 - **AZENCO5 LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/9f601de7-25b4-5a1c-9866-c8e0d060f220 - **AZENCO2 LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/10676c92-cbd8-50d2-91dd-3f95b181b950 - **ASTRAPHARM** (beneficial owner) — 100% — https://whiteintel.dev/entity/111cbdcc-95d0-5e53-bac3-0aa9320e2af4 - **AZENCO6 LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/f93bc8b3-da3d-52e4-be92-ca4421852567 - **ASTRAZENECA SWEDEN INVESTMENTS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/f644b213-9df3-5e6b-8495-c95271e8c9d6 - **AZENCO4 LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/302f2d13-68e9-5a0f-803e-c8cc496f6814 - **ZENECA FINANCE (NETHERLANDS) COMPANY** (beneficial owner) — 100% — https://whiteintel.dev/entity/025add90-4941-5151-a8d9-34a31fe00317 - **Entasis Therapeutics Holdings Inc.** (beneficial owner) — 50% — https://whiteintel.dev/entity/685b5ea2-e329-55ac-9b56-da64c5416b43 - **ASTRAZENECA SWEDEN INVESTMENTS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/f644b213-9df3-5e6b-8495-c95271e8c9d6 - **AZENCO2 LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/10676c92-cbd8-50d2-91dd-3f95b181b950 - **ARDEA BIOSCIENCES LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/f8b9d180-3db3-56ac-8745-3dfea8b2bf47 ### UBO chain (walk to the ultimate owner) A **6-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing. ## Company profile (live · UK Companies House) - **Company number:** `02910116` - **Status:** active - **Type:** ltd - **Incorporated:** 1994-03-18 - **Registered office:** 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA, United Kingdom - **SIC:** 70100 ### Officers - JOHNSTONE, Camilla — secretary · appointed 2025-05-01 - BOWDEN, Matthew Shaun — director · British · appointed 2025-04-22 - COLLINS, Iain Alistair — director · British · appointed 2017-05-31 - SLADE, Jonathan Thomas Charles — director · British · appointed 2018-06-20 - BOWDEN, Matthew Shaun — secretary · appointed 2019-02-27 · resigned 2025-05-01 - JACKSON-TURNER, Katie Louise — secretary · appointed 2015-07-15 · resigned 2019-02-27 - KEMP, Adrian Charles Noel — secretary · British · appointed 2009-01-01 · resigned 2014-11-04 - LACHLAN, Cacilia Maria — nominee secretary · British · appointed 1994-03-18 · resigned 2000-08-25 - MUSKER, Graeme Harold Rankine — secretary · British · appointed 2000-08-25 · resigned 2008-12-31 - O'GRADY, Claire-Marie — secretary · appointed 2014-11-04 · resigned 2015-07-31 - BOUCHER, Brendan James — director · British · appointed 2014-09-22 · resigned 2017-12-31 - BRIMICOMBE, Ian Martin David — director · British · appointed 2006-09-11 · resigned 2017-05-31 - CHRISTIE, Sean Lloyd — director · British · appointed 2006-09-11 · resigned 2011-02-23 - COLE, John Howard — director · British · appointed 2000-08-29 · resigned 2010-03-18 - DARLINGTON, Keith Stuart — director · British · appointed 2011-02-23 · resigned 2014-11-17 - GREENFIELD, Patricia May — director · British · appointed 2011-02-23 · resigned 2014-10-17 - JUNIPER, Jane Fiona — director · British · appointed 1994-03-18 · resigned 2000-08-29 - KEMP, Adrian Charles Noel — director · British · appointed 2014-11-04 · resigned 2025-05-01 - LACHLAN, Cacilia Maria — nominee director · British · appointed 1994-03-18 · resigned 2000-08-29 - MARSH, Adrian Ross Thomas — director · British · appointed 2003-06-30 · resigned 2006-09-11 ### Beneficial owners (Persons with Significant Control) - [Astrazeneca Uk Limited](https://whiteintel.dev/entity/418262bf-abfc-4e8b-a8b4-6ecf5eb55d65) — 75–100% shares · corporate PSC · United Kingdom — since 2016-04-06 ## Provenance - OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/02910116 - companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/02910116 --- _This is the markdown-for-agents view of the WhiteIntel dossier for **ASTRAZENECA TREASURY LIMITED**. Human view: https://whiteintel.dev/entity/2763a136-67ee-56fe-abd4-5d5b1cf5dbff · Structured JSON: https://whiteintel.dev/api/public/dossier/2763a136-67ee-56fe-abd4-5d5b1cf5dbff._ _Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._